NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Osteoboost Health

Osteoboost Health

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://www.osteoboost.com/

Last Round

Series A

Extension

Apr 9, 2026

Est. Valuation

$25M

Total Funding Raised

$19.95M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Osteoboost Health is a medical technology company that has developed Osteoboost, an FDA-cleared, prescription wearable device using vibration therapy to slow bone density loss in postmenopausal women with osteopenia.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

vibration therapybone healthosteopenia treatmentwearable medical devicedigital healthnon-pharmacological interventiontelehealthfemtechbone densitymechanical stimulationpatient adherencebone lossdirect-to-consumerDTC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Osteoboost Health Comps

Public and private peers based on sector, stage, and business model.

Osteoboost Health comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Osteoboost Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionApr 9, 2026
Series A ExtensionMar 4, 2024
GrantOct 6, 2021
Series AMay 3, 2021

Key People

Founding team and executive leadership

Laura Yecies

Chief Executive Officer And Board Member, Board Member

Executive Team

Pamela M. Peeke

Chief Medical Officer

Executive Team

Priya Patel

Chief Product Officer, Chief Product Officer

Executive Team

Osteoboost Health Investors

Notable investors and investment history

Osteoboost Health investors
InvestorRounds
Emmeline VenturesSeries A Extension
Good Growth CapitalSeries A Extension, Series A
Disrupt Health Impact FundSeries A Extension
IT-Farm CorporationSeries A
AgeTech CollaborativeSeries A Extension
Astia AngelsSeries A, Series A Extension
PortfoliaSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Partnered with Midi Health for a public webinar on HRT and bone health.

  • Apr 15, 2026

    Raised $8M in early funding.

Osteoboost Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Osteoboost Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Osteoboost Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range27
Year Founded2018
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.